Royal Bank Of Canada Has Lowered Expectations for Xometry (NASDAQ:XMTR) Stock Price

Xometry (NASDAQ:XMTR) had its target price decreased by equities researchers at Royal Bank Of Canada from $64.00 to $55.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price objective indicates a potential upside of 33.22% from the company’s previous close.

Several other equities analysts have also commented on the stock. The Goldman Sachs Group upped their price target on shares of Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 5th. JPMorgan Chase & Co. increased their target price on Xometry from $55.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Weiss Ratings reissued a “sell (e+)” rating on shares of Xometry in a research report on Wednesday, January 21st. Zacks Research lowered Xometry from a “hold” rating to a “strong sell” rating in a research note on Friday, January 30th. Finally, Wedbush dropped their target price on shares of Xometry from $70.00 to $60.00 and set an “outperform” rating for the company in a research report on Wednesday. Five analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Xometry presently has a consensus rating of “Hold” and a consensus target price of $56.88.

Xometry Trading Down 7.1%

XMTR traded down $3.15 during trading on Wednesday, hitting $41.29. The company’s stock had a trading volume of 1,303,994 shares, compared to its average volume of 1,026,436. Xometry has a twelve month low of $18.59 and a twelve month high of $73.87. The stock has a market cap of $2.12 billion, a PE ratio of -33.18 and a beta of 0.86. The firm’s 50 day moving average price is $61.69 and its 200-day moving average price is $56.21. The company has a debt-to-equity ratio of 1.20, a current ratio of 3.62 and a quick ratio of 3.58.

Xometry (NASDAQ:XMTR) last announced its quarterly earnings data on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. Xometry had a negative return on equity of 6.59% and a negative net margin of 9.80%.The business had revenue of $192.40 million during the quarter, compared to the consensus estimate of $183.37 million. During the same quarter in the previous year, the business earned $0.06 earnings per share. The business’s revenue for the quarter was up 29.5% on a year-over-year basis. On average, analysts expect that Xometry will post -0.66 earnings per share for the current year.

Insider Activity

In other news, CTO Vaidyanathan Raghavan sold 3,570 shares of the business’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $66.51, for a total transaction of $237,440.70. Following the transaction, the chief technology officer directly owned 38,397 shares of the company’s stock, valued at approximately $2,553,784.47. The trade was a 8.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO James Miln sold 6,203 shares of the company’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $66.51, for a total transaction of $412,561.53. Following the completion of the transaction, the chief financial officer owned 134,397 shares of the company’s stock, valued at $8,938,744.47. This trade represents a 4.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 63,861 shares of company stock worth $4,213,697 in the last ninety days. 9.66% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Xometry

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Xometry in the fourth quarter worth about $76,393,000. Ameriprise Financial Inc. boosted its stake in Xometry by 54.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company’s stock valued at $107,029,000 after acquiring an additional 690,558 shares during the last quarter. Durable Capital Partners LP acquired a new position in Xometry during the 3rd quarter worth $36,455,000. Gilder Gagnon Howe & Co. LLC raised its stake in shares of Xometry by 248.8% in the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 859,808 shares of the company’s stock valued at $29,053,000 after purchasing an additional 613,282 shares in the last quarter. Finally, Stephens Investment Management Group LLC lifted its position in shares of Xometry by 115.2% during the fourth quarter. Stephens Investment Management Group LLC now owns 842,987 shares of the company’s stock worth $50,132,000 after purchasing an additional 451,259 shares during the last quarter. 97.31% of the stock is owned by hedge funds and other institutional investors.

Xometry News Roundup

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Record Q4 revenue and beat on key metrics — Xometry reported Q4 revenue of ~$192M (≈+30% y/y) and an EPS beat versus some consensus estimates, driven by accelerated marketplace and enterprise growth. Read More.
• Positive Sentiment: Forward growth guidance looks constructive — management outlined at least ~21% revenue growth for 2026 and issued Q1 revenue guidance (~$187–$189M) that is roughly ahead of consensus, supporting revenue momentum into 2026. Read More.
• Neutral Sentiment: CEO succession plan announced — the company disclosed a leadership transition; such changes can be neutral-to-positive if orderly but introduce short-term execution uncertainty until new leadership is fully in place. Read More.
• Neutral Sentiment: Full earnings materials and call transcripts posted — investors can review the slide deck and call transcript for details on margin dynamics, enterprise adoption and cadence of marketplace growth. Read More.
• Negative Sentiment: Analyst price-target cut — Wedbush reduced its target from $70 to $60 (while keeping an outperform rating), trimming upside expectations and likely weighing on sentiment. Read More.
• Negative Sentiment: Conflicting/unclear reporting on EPS — some transcripts and reports flagged a miss (a reported -$0.17 EPS in one transcript) that conflicts with official releases showing a positive EPS figure; the mixed messaging may have amplified selling pressure. Read More.

About Xometry

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.